Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase
Authors:
- Allan S. LewALAllan S. Lew
- Hanoch HodHHHanoch Hod
- Bojan CercekBCBojan Cercek
- Prediman K. ShahPSPrediman K. Shah
- William GanzWGWilliam Ganz
- 1 January 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (1) , 1-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Intracoronary and Intravenous Streptokinase in Acute Myocardial Infarction: A Comparative ReportEuropean Heart Journal, 1985
- Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous StreptokinaseNew England Journal of Medicine, 1985
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Time from onset of symptoms to thrombolytic therapy: A major determinant of myocardial salvage in patients with acute transmural infarctionJACC, 1985
- Improvement in regional and global left ventricular function after intracoronary thrombolysis: Assessment with two-dimensional echocardiographyThe American Journal of Cardiology, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Steroid therapy during acute myocardial infarctionThe American Journal of Medicine, 1974